The Cancer Prevention and Treatment Center has a special diagnosis and treatment center, established specialized outpatient clinics and wards, and arranged for famous experts in various disciplines and experienced medical staff to provide diagnosis and treatment. The good environment and high-quality services have been welcomed by people from all walks of life overseas.

For more than ten years, the hospital has treated various types of cancer patients from Hong Kong, Macao and Taiwan, overseas Chinese and 25 countries and regions, with a total of 70,000 patients.

The hospital always adheres to the patient-centered approach and is the first among similar hospitals in the country to implement computer network management, implement paperless prescriptions in wards, launch telephone appointments for doctor consultations, magnetic card registration, and trial outpatient computer diagnosis systems, remote consultation services and other new initiatives, which have greatly contributed to the success of the hospital.

It is convenient for patients and shortens the waiting time by more than half.

In line with the needs of social development, the center has built a 25-story medical and scientific research building of 88,000 square meters with a height of 88,000 square meters and a capacity of 1,000 beds.

The building adopts computer network intelligent management, fully enclosed central air-conditioning, and rail logistics automated medical transportation systems. All equipment is in sync with international standards. It was completed and put into use on November 23, 2002, becoming the largest oncology medical teaching and research base in Asia.

In 2007, the center currently has 923 employees, including 694 health technicians, 26 with senior professional titles, 92 with deputy senior titles, and 249 with intermediate professional titles. It has 514 beds, of which 900 are actually open.

The annual outpatient and emergency department visits are 240,000, and the annual new cancer cases received are about 10,000, accounting for 18% of the new cancer cases in Guangdong Province. The hospital has 8,000 hospitalizations, ranking first among more than 100 specialized cancer hospitals in the country.

The hospital provides a large number of medical and health services to Hong Kong and Macao compatriots and overseas Chinese patients in South China.

The hospital's overall tumor diagnosis and treatment level and medical quality have strong advantages.

Internationally, cancer diagnosis and treatment methods such as surgery, radiotherapy, chemotherapy, intervention, immunity, genes and traditional Chinese medicine are all available.

The diagnosis and treatment level of nasopharyngeal cancer and the 5-year survival rate have reached the internationally advanced level.

Other common tumors such as head and neck tumors, esophageal cancer, lung cancer, breast cancer, liver cancer, colorectal cancer, cervical cancer, ovarian cancer, lymphoma, etc. The clinical treatment efficacy and clinical scientific research level are domestically first-class and internationally advanced.

In order to further improve the quality of medical care, the center is the first in the country to launch the chief expert responsibility system for single types of tumors, formulate comprehensive treatment standards for common tumors, and determine the optimal individualized treatment plan based on each patient's condition and actual situation.

Achieve the best therapeutic effect.

In 2010, the center had more than 1,500 employees, including 236 with senior professional titles, 2 academicians of the Chinese Academy of Sciences (including 1 part-time), 48 doctoral supervisors, 97 master's supervisors, and more than 350 postgraduate students.

There are 70 oncology specialists and training physicians***, and more than 90 one-year oncology trainees. Master's degree enrollment majors: oncology, imaging medicine and nuclear medicine, anesthesiology, molecular medicine; doctoral degree enrollment majors: oncology,

Molecular medicine.

The center has 1,072 hospital beds and treats patients from all over the country and Southeast Asia. The annual outpatient visits reach 370,000 and more than 34,000 are discharged. The number is increasing steadily year by year.

It has internal medicine, radiotherapy, nasopharyngology, head and neck, thoracic, breast, colorectal, gastroenteropancreatic, hepatobiliary, urological oncology surgery, neuro-oncology surgery, gynecology, imaging and minimally invasive interventional center, and traditional Chinese medicine department.

, hematology and oncology, endoscopic laser and biotherapy and other specialties.

The center provides patients with comprehensive cancer treatment, including surgery, radiotherapy, chemotherapy, interventional, minimally invasive, biological and traditional Chinese medicine treatments.

In 1998, the center was the first among its peers in China to launch the system of chief expert responsibility for a single tumor type, formulate and implement comprehensive treatment specifications for a single type of tumor, create a personalized treatment plan for each patient, and create a platform for cancer hospitals to develop their own characteristics.

The direction has also attracted many domestic colleagues to come to exchange and learn.

The center has continuously revised and improved the diagnosis and treatment specifications for each type of tumor, and formulated clinical pathways for diagnosis and treatment of each major type of disease.

In August 2008, the center launched a multidisciplinary joint clinic for eight common tumors, which facilitates patients' medical treatment, especially the diagnosis and treatment of difficult patients, and brings good news to patients. It has received widespread attention from major media and praise from the society.

Scale and advantages of the Head and Neck Department: There are currently 2 wards and 72 beds.

There are 7 professionals with senior professional titles, including 2 doctoral supervisors and 4 master supervisors. It is one of the head and neck tumor specialists with the strongest professional and technical strength in China and has a high academic status at home and abroad.

Features and Achievements: Mainly diagnoses and treats benign and malignant tumors of the head and neck, including: laryngeal cancer, thyroid tumors, oral tumors, salivary gland tumors, nasal cavity and paranasal sinus tumors, nasopharynx, oropharynx and hypopharynx cancer, nasopharyngeal fibroangioma,

Head and neck skin tumors, angiomas, eye tumors, etc.

After years of improvement and improvement, cervical lymph node dissection has become a standard surgical procedure, and its characteristics have been recognized by domestic and foreign academic circles.

Based on years of scientific research and clinical research, radical surgery and comprehensive treatment for laryngeal cancer that preserve laryngeal function have been carried out to improve the quality of life of laryngeal cancer patients.

Comprehensive treatment methods such as surgery combined with chemotherapy and local three-dimensional radiotherapy are used to implement rescue treatment for nasopharyngeal cancer lesions after radiotherapy failure, and achieve good results.